Ligand profile
36P
Ligand co-crystallized with a similar protein (Protein Data Bank).
Bound to: KP13_04919 — 3-oxoacyl-[acyl-carrier-protein] reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
36P- PDB
4bo6- UniProt (similar protein)
O54438- Target protein
- KP13_04919
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 33.2
- −1 ≤ LogP ≤ 5 4.07
- MW ≤ 500 Da 312.4
- LogP ≤ 5 4.07
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 4
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 33.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc2c(c1)CCN2C(=O)c3csc(n3)c4ccsc4c1ccc2c(c1)CCN2C(=O)c3csc(n3)c4ccsc4
InChI=1S/C16H12N2OS2/c19-16(18-7-5-11-3-1-2-4-14(11)18)13-10-21-15(17-13)12-6-8-20-9-12/h1-4,6,8-10H,5,7H2InChI=1S/C16H12N2OS2/c19-16(18-7-5-11-3-1-2-4-14(11)18)13-10-21-15(17-13)12-6-8-20-9-12/h1-4,6,8-10H,5,7H2
IJYXCHGILIEIHU-UHFFFAOYSA-NIJYXCHGILIEIHU-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- PDB
- Binding sites
- PF13561
External resources
Open this ligand in third-party databases and cheminformatics tools.
- PDB RCSB ligand 36P →
- PDB RCSB structure 4bo6 →
- UniProt UniProt O54438 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “36P”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_04919.
PDB 17
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).